ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 665564 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 665564; 2) Community: the network communities that were significantly associated with the response to NSC 665564; 3) Molecule: the relationships between components within communities and NSC 665564; 4) MDR: the compounds that were significantly associated with the NSC 665564.

NSC Compound Enrichment Correlation
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0385613993886001 0.55515978
NSC 615534 Null 0.0385613993886001 -0.11181156
NSC 621727 Null 0.0385613993886001 0.52647083
NSC 625502 Antimony, chlorobis(4-morpholinecarbodithioato-S,S')-, 0.0385613993886001 0.37595973
NSC 627666 1H-Benzo[de]-1,3-benzodioxolo[5,6]quinoline-6a- carbonitrile, 6-benzoyl-1,2-dimethoxy- 0.0385613993886001 -0.32248547
NSC 633514 Null 0.0385613993886001 0.069207757
NSC 635449 Copper, chloro[2-[1-(2-pyridinyl)ethylidene][N,N-dipropyl-hydrazinecarbothioamidato-N,N,S]- 0.0385613993886001 0.4250867
NSC 637411 Null 0.0385613993886001 0.22437027
NSC 63878 Cytarabine Hydrochloride AZ 0.0385613993886001 0.42889303
NSC 639514 Cyclopentanone, 2-[(dimethylamino)methyl]-5- [[4-[(propionyloxy)methoxy]phenyl]methylene]-, hydrochloride 0.0385613993886001 0.27975967
Total:109  Current:75    [First] [Prev] [Next] [Last]